9 April 2026
By Publisher Ray Carmen
In a quiet but powerful breakthrough emerging from South Asia, a Sri Lankan innovator is harnessing artificial intelligence to tackle one of the world’s fastest-growing causes of preventable blindness — diabetic eye disease.
At the centre of this transformation is Dr. Dhanushi Hettiarachchi, founder of Ophtha Innovations, a Colombo-based MedTech company using AI to detect diabetic retinopathy at its earliest and most treatable stages.
A Silent Global Threat
Diabetic retinopathy — a complication of diabetes that damages the retina — is a leading cause of vision loss worldwide. The danger lies in its silence: patients often experience no symptoms until irreversible damage has already begun.
Early detection is critical. Yet across much of the world, access to eye specialists remains limited, leading to delayed diagnoses and avoidable blindness.
AI Meets Eye Care
This is where Ophtha Innovations steps in.
The company has developed AI-powered diagnostic tools capable of analysing retinal images and identifying early signs of disease with remarkable speed and accuracy. By integrating AI into routine eye exams, the system allows frontline healthcare providers — not just specialists — to detect risks early and refer patients for timely treatment.
Crucially, the technology is designed to work with existing medical equipment, transforming standard fundus cameras into intelligent screening tools powered by locally trained datasets.
As Dr. Hettiarachchi has emphasised, strong, locally relevant datasets are key to making AI effective in real-world clinical settings — particularly in emerging markets where healthcare infrastructure varies widely.
Scaling Access, Saving Sight
The implications are profound.
By embedding AI into everyday healthcare environments — from clinics to optician services — Ophtha’s model creates a scalable screening network capable of reaching high-risk patients earlier than ever before.
This approach not only reduces the burden on overstretched specialists but also brings preventive care closer to communities that need it most.
Globally, AI is already proving its potential in eye care. Clinical studies show advanced algorithms can detect diabetic retinopathy with high sensitivity and accuracy, sometimes rivaling human specialists while dramatically improving efficiency.
A Glimpse Into the Future of Medicine
What makes this story remarkable is not just the technology — but its origin.
From Sri Lanka, a nation often overlooked in global tech narratives, a new generation of innovators is building solutions with worldwide impact. Ophtha Innovations represents a shift toward inclusive, locally driven innovation — where global health challenges are solved from the ground up.
Final Word
In an age where artificial intelligence is often associated with automation and disruption, this is a story of prevention, accessibility, and human impact.
Because in the fight against blindness, the greatest breakthrough isn’t just seeing the future — it’s ensuring millions don’t lose their sight before they ever realise they’re at risk.
